Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019

Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic and biological information in order to optimise the therapeutic benefit relative to the possibility of side-effects for each individual. Recent clinical trials have shown that higher blood eosinophil counts are associated with a greater efficacy of inhaled corticosteroids (ICSs) in chronic obstructive pulmonary disease (COPD) patients. Blood eosinophil counts are a biomarker with potential to be used in clinical practice, to help target ICS treatment with more precision in COPD patients with a history of exacerbations despite appropriate bronchodilator treatment.The Global Initiative for Chronic Obstructive Lung…

• AT
  American Thoracic Society
• P
  Pfizer
• A
  AstraZeneca
• G
  GlaxoSmithKline
• S
  Sanofi
• GS
  Gilead Sciences
• B
  Biogen
• TP
  Teva Pharmaceutical Industries
• CF
  Chiesi Farmaceutici
• CB
  CSL Behring
• S
  Sunovion
• RP
  Regeneron Pharmaceuticals
• V
  Veracyte
• YU
  York University
• NI
  National Institute for Health and Care Research
• BF
  Bundesministerium für Bildung und Forschung
• G
  Grifols
• NI
  National Institutes of Health
• G
  Genentech
• MB
  Manchester Biomedical Research Centre